Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study
Acta Obstetricia et Gynecologica Scandinavica, Volume 92, No. 8, Year 2013
Notification
URL copied to clipboard!
Description
Objective To compare pregnancy outcomes in cutaneous lupus erythematosus (CLE) with systemic lupus erythematosus (SLE) and healthy pregnant women. Design Cohort comparative study. Setting Two university maternity centers in Saudi Arabia and Egypt. Population Pregnant women with CLE and SLE and healthy pregnant women. Methods Over a three-year period, 201 participants were allocated to three groups: group 1 (n = 67) contained women with CLE, group 2 (n = 67) women with SLE, and group 3 healthy controls (n = 67). Diagnosis of lupus erythematosus was based on American College of Rheumatology criteria. All participants were followed until delivery. Lupus exacerbation was evaluated by Lupus Activity Index score. ANOVA and chi-squared tests were used to compare obstetrical and neonatal outcomes, and regression analysis was used to define independent factors of adverse pregnancy outcomes. Main outcome measures Pregnancy losses, preterm labor, intrauterine growth restriction, preeclampsia, neonatal intensive care unit admissions, cesarean sections and lupus exacerbations. Results There was no significant difference between groups 1 and 3 in rates of pregnancy loss, preterm labor, preeclampsia, intrauterine growth restriction and neonatal intensive care admission. Group 1 had lower pregnancy loss (p = 0.005), growth restriction (p = 0.001), preeclampsia (p = 0.05), neonatal intensive care admissions (p = 0.001), cesarean section (p = 0.03), lupus exacerbations (p = 0.05) and anti-phospholipid antibodies (p = 0.02) compared with group 2. In groups 1 and 2, lupus exacerbation and anti-phospholipid antibodies were significant independent factors for adverse outcomes. Conclusions Cutaneous lupus erythematosus means comparable pregnancy outcomes to those of the healthy population. Lower rates of disease exacerbation and anti-phospholipid antibodies are potential factors for better pregnancy outcome in CLE compared with SLE. © 2013 Nordic Federation of Societies of Obstetrics and Gynecology.
Authors & Co-Authors
Hamed, Hossam O.
Saudi Arabia, Buraidah
Al Qassim University
Egypt, Asyut
Assiut University
Ahmed, Salah Roshdy
Saudi Arabia, Buraidah
Al Qassim University
Alzolibani, Abdullateef A.
Saudi Arabia, Buraidah
Al Qassim University
Kamal, Manal Mohamed
Saudi Arabia, Buraidah
Al Qassim University
Egypt, Asyut
Assiut University
Mostafa, Marwa Salah
Saudi Arabia, Buraidah
Al Qassim University
Gamal, Rania M.
Egypt, Asyut
Assiut University
Atallah, Dalia A.A.
Egypt, Asyut
Assiut University
Abd-El-Aall, Diaa Eldeen M.
Egypt, Asyut
Assiut University
Statistics
Citations: 29
Authors: 8
Affiliations: 2
Identifiers
Doi:
10.1111/aogs.12158
ISSN:
00016349
e-ISSN:
16000412
Research Areas
Maternal And Child Health
Sexual And Reproductive Health
Study Design
Cross Sectional Study
Cohort Study
Study Approach
Quantitative
Study Locations
Egypt
Participants Gender
Female